Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
about
The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumoniaImmune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoireTh1 cytokines facilitate CD8-T-cell-mediated early resistance to infection with Mycobacterium tuberculosis in old mice.A population-based analysis of pneumococcal disease mortality in California, 1989-1998.Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.Treatment and prevention of acute respiratory infections among Iranian hajj pilgrims: a 5-year follow up study and review of the literatureAdverse events after pneumococcal vaccination.Influence of asthma status on serotype-specific pneumococcal antibody levels.Explaining trends in hospitalizations for pneumonia and influenza in the elderly.Economic Evaluation of Standing Order Programs for Pneumococcal Vaccination of Hospitalized Elderly PatientsOlder Human B Cells and Antibodies
P2860
Q21261529-743DBD03-8030-4239-9316-BD9225370AC9Q23911823-2D314B2C-0DC7-484C-9749-64B49ACC31FEQ24812252-5686F095-8DB5-423C-94D8-F89A9F5015C8Q34111761-1140B357-802F-46BC-90C7-06946B873140Q34681139-1091E405-DEA6-43C9-8227-332F32FB0103Q34757031-DEBBCDFC-4FCC-43D1-91A1-DE5FB72C986AQ35874108-F477528C-444E-421D-A6FF-DF903782101AQ37843509-ED381B9C-FE05-46E1-91FE-C7D68171AF26Q40447224-BE551603-F1FB-4A49-AAA5-D78B658199F7Q43575667-6E6B4786-B833-4744-BF0A-CFC227EC7203Q50769654-0B38744E-9108-4811-A94D-C9AA2044B4A3Q57084024-2BF9DB2E-43D0-4C85-B1DF-55E03B0ABB7FQ58045450-299197B3-5064-40F9-B8EC-9866F7AF7861
P2860
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@ast
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@en
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@nl
type
label
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@ast
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@en
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@nl
prefLabel
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@ast
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@en
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@nl
P1433
P1476
Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
@en
P2093
P304
P356
10.2165/00002512-200118050-00001
P577
2001-01-01T00:00:00Z
P6179
1041983941